Amgen (AMGN) Gross Margin (2009 - 2026)

Amgen has reported Gross Margin for 18 years, with the latest figure at 72.04% in Q2 2026.

• On a quarterly basis, Gross Margin rose 484.0% year-over-year to 72.04% in Q2 2026; TTM through Jun 2026 was 69.52%, a 503.0% increase from a year earlier, with the FY2025 full-year figure at 67.25%, up 572.0% from the prior year.
• Gross Margin was 72.04% for Q2 2026 at Amgen, up from 68.16% in the prior quarter.
• The five-year high for Gross Margin was 77.1% in Q2 2022, with the low at 280.61% in Q4 2022.
• Average Gross Margin over 5 years is 49.07%, with a median of 67.96% recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Gross Margin tumbled 35552 bps in 2022, then jumped 34264 bps in 2023.
• Over 5 years, Gross Margin stood at 280.61% in 2022, then soared by 122 bps to 62.03% in 2023, then gained by 6 bps to 65.75% in 2024, then grew by 6 bps to 69.84% in 2025, then grew by 3 bps to 72.04% in 2026.
• The last three Gross Margin figures came in at 72.04% (Q2 2026), 68.16% (Q1 2026), and 69.84% (Q4 2025), per Business Quant data.